In one aspect, compositions and wound dressings are described herein. In some embodiments, a composition or wound dressing described herein comprises a mesh formed from a plurality of biodegradable polymer fibers; a first active agent dispersed in the biodegradable polymer fibers; a plurality of biodegradable polymer particles disposed in the mesh; and a second active agent dispersed in the biodegradable polymer particles. The particles can be disposed within the interiors of the fibers of the mesh or between the fibers of the mesh. In another aspect, a composition or wound dressing described herein comprises a first perforated mesh formed from a first plurality of biodegradable polymer fibers; and a second perforated mesh formed from a second plurality of biodegradable polymer fibers, wherein the second perforated mesh is disposed on the first perforated mesh in a stacked configuration and the first and second perforated meshes have different degrees of perforation.

In one aspect, compositions and wound dressings are described herein. In some embodiments, a composition or wound dressing described herein comprises a mesh formed from a plurality of biodegradable polymer fibers; a first active agent dispersed in the biodegradable polymer fibers; a plurality of biodegradable polymer particles disposed in the mesh; and a second active agent dispersed in the biodegradable polymer particles. The particles can be disposed within the interiors of the fibers of the mesh or between the fibers of the mesh. In another aspect, a composition or wound dressing described herein comprises a first perforated mesh formed from a first plurality of biodegradable polymer fibers; and a second perforated mesh formed from a second plurality of biodegradable polymer fibers, wherein the second perforated mesh is disposed on the first perforated mesh in a stacked configuration and the first and second perforated meshes have different degrees of perforation.

Injectable composition in hydrogel form, comprising water and micronized croscarmellose sodium. Method for preparing said injectable composition comprising mixing the components and heat treating the obtained composition at a temperature between 90° C. and 150° C., preferably between 100° C. and 130° C.

Injectable composition in hydrogel form, comprising water and micronized croscarmellose sodium. Method for preparing said injectable composition comprising mixing the components and heat treating the obtained composition at a temperature between 90° C. and 150° C., preferably between 100° C. and 130° C.

The present disclosure relates generally to a particulate product. The particulate product comprises coarse particles of a nonionic synthetic associative thickener (NSAT) rheology modifier. The NSAT rheology modifier is selected from the group consisting of hydrophobically-modified ethoxylated urethane (HEUR), hydrophobically-modified polyacetal-polyether (HMPAPE), and combinations thereof. The particulate product is incorporated into a waterborne paint formula.

The present disclosure relates generally to a particulate product. The particulate product comprises coarse particles of a nonionic synthetic associative thickener (NSAT) rheology modifier. The NSAT rheology modifier is selected from the group consisting of hydrophobically-modified ethoxylated urethane (HEUR), hydrophobically-modified polyacetal-polyether (HMPAPE), and combinations thereof. The particulate product is incorporated into a waterborne paint formula.

The present disclosure relates to a wound treatment dressing in which an absorbent layer comprises an odour-inhibiting mixture; wherein the odour-inhibiting mixture comprises coffee grounds. More particularly, a wound treatment dressing is provided for the absorption of odours in wounds, including pressure ulcers, leg ulcers, cancerous wounds, diabetic foot ulcers, burns, traumatic or surgical wounds, which comprises an odour-inhibiting mixture with coffee grounds.

The present disclosure relates to a wound treatment dressing in which an absorbent layer comprises an odour-inhibiting mixture; wherein the odour-inhibiting mixture comprises coffee grounds. More particularly, a wound treatment dressing is provided for the absorption of odours in wounds, including pressure ulcers, leg ulcers, cancerous wounds, diabetic foot ulcers, burns, traumatic or surgical wounds, which comprises an odour-inhibiting mixture with coffee grounds.

The present invention is directed to a flowable hemostatic paste comprising a crosslinked carboxymethyl cellulose and at least one non-toxic dispersant. More specifically the present invention relates to a hemostatic paste containing citric acid cross-linked CMC, which is suspended or dispersed as a powder in a mixture of a first non-toxic glycerol-containing hygroscopic dispersant and a second non-toxic alcohol functionalized dispersant comprising propylene glycol or 1,3-butanediol.

The present invention is directed to a flowable hemostatic paste comprising a crosslinked carboxymethyl cellulose and at least one non-toxic dispersant. More specifically the present invention relates to a hemostatic paste containing citric acid cross-linked CMC, which is suspended or dispersed as a powder in a mixture of a first non-toxic glycerol-containing hygroscopic dispersant and a second non-toxic alcohol functionalized dispersant comprising propylene glycol or 1,3-butanediol.